The Future of Medicine
Our vision is to continue to drive the development and accelerate the delivery of world-leading gene and gene-modified cell therapies to improve the health of all Australians.
A new collaboration between Children’s Medical Research Institute (CMRI) and Bloomsbury Genetic Therapies Limited (Bloomsbury), a clinical-stage biotechnology company based in the UK, could see a novel gene therapy for a devastating genetic liver metabolic condition enter clinical trials within months – providing hope for children who currently have to undergo liver transplantation to survive.…
Exciting news today about the world-first delivery of a gene therapy at Westmead.
Researchers have for the first time calculated the lifetime cost of living with an inherited eye disease in Australia as $5.2 million per person. Distressingly, a significant portion of the cost associated with the progressive loss of vision is absorbed by the individuals affected and their families, with over one-third of these costs being due…
Get new content delivered directly to your inbox.
Australian Genome Therapeutics Centre is a joint initiative of